Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series

Craig Lammert, Nadia Blessing, Maaz Arif, Divya Minnaganti, Regina Weber, Kelsey Green, Raj Vuppalanchi, Naga Chalasani

Open source

DOI
10.1016/j.gastha.2026.101095
Published
2026
Container
Gastro Hep Advances
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gastha.2026.101095,
  title = {Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series},
  author = {Craig Lammert and Nadia Blessing and Maaz Arif and Divya Minnaganti and Regina Weber and Kelsey Green and Raj Vuppalanchi and Naga Chalasani},
  year = {2026},
  journal = {Gastro Hep Advances},
  doi = {10.1016/j.gastha.2026.101095},
  url = {https://doi.org/10.1016/j.gastha.2026.101095}
}

RIS

TY  - JOUR
TI  - Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series
AU  - Craig Lammert
AU  - Nadia Blessing
AU  - Maaz Arif
AU  - Divya Minnaganti
AU  - Regina Weber
AU  - Kelsey Green
AU  - Raj Vuppalanchi
AU  - Naga Chalasani
PY  - 2026
JO  - Gastro Hep Advances
DO  - 10.1016/j.gastha.2026.101095
UR  - https://doi.org/10.1016/j.gastha.2026.101095
ER  - 

APA

Lammert, C., Blessing, N., Arif, M., Minnaganti, D., Weber, R., Green, K., Vuppalanchi, R., & Chalasani, N. (2026). Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series. Gastro Hep Advances. https://doi.org/10.1016/j.gastha.2026.101095

Source records